Multimodal oculomotor assessment reveals prodromal markers of Parkinson’s disease in non-manifesting LRRK2 G2019S mutation carriers
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Multimodal oculomotor assessment reveals prodromal markers of Parkinson’s disease in non-manifesting LRRK2 G2019S mutation carriers ; volume:10 ; number:1 ; day:19 ; month:12 ; year:2024 ; pages:1-13 ; date:12.2024
npj Parkinson's Disease ; 10, Heft 1 (19.12.2024), 1-13, 12.2024
- Urheber
-
Riek, Heidi C.
Visanji, Naomi P.
Pitigoi, Isabell C.
Di Luca, Daniel G.
Armengou-Garcia, Laura
Ahmed, Nazish
Perkins, Julia E.
Brien, Donald C.
Huang, Jeff
Coe, Brian C.
Huang, Jana
Ghate, Taneera
Lang, Anthony E.
Marras, Connie
Munoz, Douglas P.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41531-024-00840-w
- URN
-
urn:nbn:de:101:1-2503020635588.139615277138
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:26 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Riek, Heidi C.
- Visanji, Naomi P.
- Pitigoi, Isabell C.
- Di Luca, Daniel G.
- Armengou-Garcia, Laura
- Ahmed, Nazish
- Perkins, Julia E.
- Brien, Donald C.
- Huang, Jeff
- Coe, Brian C.
- Huang, Jana
- Ghate, Taneera
- Lang, Anthony E.
- Marras, Connie
- Munoz, Douglas P.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Sex-dependent interactions between prodromal intestinal inflammation and LRRK2 G2019S in mice promote endophenotypes of Parkinson’s disease
Neuropathology of incidental Lewy body & prodromal Parkinson’s disease
LRRK2 contributes to monocyte dysregulation in Parkinson’s disease
LRRK2 and neuroinflammation: partners in crime in Parkinson’s disease?
Crystallizing the Parkinson’s disease protein LRRK2 under microgravity conditions
A look back at the prodromal findings in Parkinson’s disease
Fibroblast Biomarkers of Sporadic Parkinson’s Disease and LRRK2 Kinase Inhibition
Structural basis for Parkinson’s disease-linked LRRK2’s binding to microtubules
Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance
A designed ankyrin-repeat protein that targets Parkinson’s disease-associated LRRK2
Pathophysiological evaluation of the LRRK2 G2385R risk variant for Parkinson’s disease
Externally validated deep learning model to identify prodromal Parkinson’s disease from electrocardiogram
Sex-dependent interactions between prodromal intestinal inflammation and LRRK2 G2019S in mice promote endophenotypes of Parkinson’s disease
Neuropathology of incidental Lewy body & prodromal Parkinson’s disease
LRRK2 contributes to monocyte dysregulation in Parkinson’s disease
LRRK2 and neuroinflammation: partners in crime in Parkinson’s disease?
Crystallizing the Parkinson’s disease protein LRRK2 under microgravity conditions
A look back at the prodromal findings in Parkinson’s disease
Fibroblast Biomarkers of Sporadic Parkinson’s Disease and LRRK2 Kinase Inhibition
Structural basis for Parkinson’s disease-linked LRRK2’s binding to microtubules
Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance
A designed ankyrin-repeat protein that targets Parkinson’s disease-associated LRRK2
Pathophysiological evaluation of the LRRK2 G2385R risk variant for Parkinson’s disease
Externally validated deep learning model to identify prodromal Parkinson’s disease from electrocardiogram
Sex-dependent interactions between prodromal intestinal inflammation and LRRK2 G2019S in mice promote endophenotypes of Parkinson’s disease
Neuropathology of incidental Lewy body & prodromal Parkinson’s disease
LRRK2 contributes to monocyte dysregulation in Parkinson’s disease
LRRK2 and neuroinflammation: partners in crime in Parkinson’s disease?
Crystallizing the Parkinson’s disease protein LRRK2 under microgravity conditions
A look back at the prodromal findings in Parkinson’s disease
Fibroblast Biomarkers of Sporadic Parkinson’s Disease and LRRK2 Kinase Inhibition
Structural basis for Parkinson’s disease-linked LRRK2’s binding to microtubules
Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance
A designed ankyrin-repeat protein that targets Parkinson’s disease-associated LRRK2
Pathophysiological evaluation of the LRRK2 G2385R risk variant for Parkinson’s disease